{"_id": "650d0f47c9669d2e208ec2dc", "$and": [{"$and": [{"$and": [{"age": {"$gte": 18, "$lte": 79}}, {"diagnosis": "locoregionally recurrent or second primary HNSCC in a previously radiated field"}]}, {"surgery": {"$lte": 8}}]}, {"$and": [{"$or": [{"margins": {"$ne": "negative"}}, {"dysplasia": "high grade"}]}, {"ENE": {"$exists": true}}]}, {"PD-L1 CPS": {"$gte": 1}}, {"prior radiation": {"$gt": 50}}, {"completed prior radiation": {"$gte": 180}}, {"no evidence of distant disease": true}, {"no anti-PD-1/PD-L1 therapy": true}, {"ECOG performance status": {"$in": [0, 1]}}, {"able to consent": true}, {"$or": [{"pregnant": false}, {"breastfeeding": false}]}, {"$and": [{"expecting to conceive or father children": false}, {"contraception": {"$exists": true}}]}, {"ANC": {"$gte": 1500}}, {"platelets": {"$gte": 100000}}, {"total bilirubin": {"$lte": 1.5}}, {"AST/ALT": {"$lte": 3}}, {"creatinine clearance": {"$gt": 30}}, {"no current active infection": true}, {"no history of non-infectious pneumonitis": true}, {"no history of solid organ transplant or stem cell transplant": true}, {"$not": {"$and": [{"no immunosuppressive medication": false}, {"$or": [{"steroids": {"$in": ["intranasal", "inhaled", "topical", "local"]}}, {"systemic corticosteroids": {"$lte": 10}}, {"steroids as premedication": true}]}]}}, {"cardiac function": {"$exists": true}}, {"no live vaccine": true}, {"$not": {"$and": [{"severe hypersensitivity": {"$lt": 3}}, {"$and": [{"no active autoimmune disease": true}, {"replacement therapy": true}]}]}}, {"no known psychiatric or substance abuse disorder": true}, {"HIV-infected patients": {"$exists": true}}, {"$not": {"$or": [{"hepatitis B": true}, {"hepatitis C": true}]}}], "nctId": "NCT04671667", "title": "A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features"}